These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15923141)

  • 41. A brief introduction to the research achievement on the strategy and technical measures for interrupting the transmission of lymphatic filariasis in China.
    Shi ZJ; Sun DJ; Wang ZJ; Tao ZH; Pan SX; Liu XJ; Zhang SQ; Ou ZY; Zhu SZ; Li QJ; Chang J; Wu RZ; Deng SS; Zheng XQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(2):110-2. PubMed ID: 12572001
    [No Abstract]   [Full Text] [Related]  

  • 42. Control of filariasis in India.
    Rao CK; Sharma SP
    J Commun Dis; 1986 Dec; 18(4):276-82. PubMed ID: 3309032
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 44. 489 Global programme to eliminate lymphatic filariasis: progress report, 2014.
    Wkly Epidemiol Rec; 2015 Sep; 90(38):489-504. PubMed ID: 26387149
    [No Abstract]   [Full Text] [Related]  

  • 45. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
    [No Abstract]   [Full Text] [Related]  

  • 46. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
    Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
    Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
    Pani SP; Das LK; Vanamail P
    J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2009 Oct; 84(42):437-44. PubMed ID: 19860021
    [No Abstract]   [Full Text] [Related]  

  • 50. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
    [No Abstract]   [Full Text] [Related]  

  • 51. Recent advances in the chemotherapy of lymphatic filariasis.
    Navaratnam V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.
    Curtis CF; Malecela-Lazaro M; Reuben R; Maxwell CA
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S97-104. PubMed ID: 12625923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
    Rajendran R; Mani TR; Munirathinam A; Sunish IP; Abdullah SM; Augustin DJ; Satyanarayana K
    Trans R Soc Trop Med Hyg; 2003; 97(3):355-9. PubMed ID: 15228259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New goals set for filariasis elimination in India.
    Sharma DC
    Lancet Infect Dis; 2002 Jul; 2(7):389. PubMed ID: 12127343
    [No Abstract]   [Full Text] [Related]  

  • 55. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 56. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 57. A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
    Babu BV
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):44-5. PubMed ID: 15906640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphatic filariasis.
    Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass drug administration to treat lymphatic filariasis.
    Ravindran B
    Lancet; 2002 Jun; 359(9321):1948. PubMed ID: 12057582
    [No Abstract]   [Full Text] [Related]  

  • 60. Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 Sep; 78(36):315-7. PubMed ID: 14518107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.